August 9, 2019
![](https://jillrobertsibdcenter.weillcornell.org/sites/default/files/news_images/battat1.png)
JRC physician Dr. Robert Battat presented his findings at Digestive Disease Week 2019 demonstrating the efficacy of a serum-based biomarker assay in identifying mucosal inflammation with similar accuracy to fecal calprotectin in patients with Crohn’s disease
Category:
News and Announcements